Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Idioma
Intervalo de año de publicación
1.
Vestn Khir Im I I Grek ; 157(1): 39-43, 1998.
Artículo en Ruso | MEDLINE | ID: mdl-9611313

RESUMEN

The method of enteral correction was clinically studied in complex treatment of 20 patients with massive blood loss. An especially elaborated solution identical in its composition to chyme was used for the intravenous infusion. Mafusol was used for anti-ischemic defense of the intestine. The intestinal therapy at the early postoperative period allows effective elimination of hypovolemia, stabilization of the central hemodynamics indices, the earlier reestablishment of functional activity of the gastrointestinal tract. The enteral correction results in 30% less total volume of the intravenous infusion therapy and less amount of complications resulting from it.


Asunto(s)
Nutrición Enteral , Formiatos/administración & dosificación , Hemorragia/terapia , Hemostáticos/administración & dosificación , Heridas y Lesiones/complicaciones , Volumen Sanguíneo , Hemodinámica , Hemorragia/etiología , Hemorragia/fisiopatología , Humanos , Infusiones Intravenosas , Traumatismo Múltiple/complicaciones , Traumatismo Múltiple/cirugía , Cuidados Posoperatorios , Soluciones , Factores de Tiempo , Heridas y Lesiones/cirugía
2.
Voen Med Zh ; (12): 29-32, 80, 1994 Dec.
Artículo en Ruso | MEDLINE | ID: mdl-7900315

RESUMEN

The authors have studied the efficiency of new blood substitutes (polyoxidin and mafusol) in complex infusion-transfusion therapy in operations on lungs. During surgical interventions these medications were administered in doses of 717.0 +/- 30.0 ml and 914.0 +/- 74.0 correspondingly, and one day after the operation--400 ml each. Operational blood losses were 1.25 +/- 0.9 l. It was found out that polyoxidin and mafusol have executed positive influence upon various factors of pathophysiological mechanisms, and thus were effective in complex treatment of blood losses or shock states.


Asunto(s)
Pérdida de Sangre Quirúrgica , Sustitutos Sanguíneos/uso terapéutico , Formiatos/uso terapéutico , Hemostáticos/uso terapéutico , Polietilenglicoles , Equilibrio Ácido-Base/efectos de los fármacos , Enfermedad Aguda , Pérdida de Sangre Quirúrgica/fisiopatología , Sustitutos Sanguíneos/farmacología , Evaluación de Medicamentos , Formiatos/farmacología , Hemodinámica/efectos de los fármacos , Hemostáticos/farmacología , Humanos , Pulmón/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA